Xinchun Tong

3.4k total citations
52 papers, 1.7k citations indexed

About

Xinchun Tong is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Xinchun Tong has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Pharmacology. Recurrent topics in Xinchun Tong's work include Cannabis and Cannabinoid Research (9 papers), Mass Spectrometry Techniques and Applications (7 papers) and Analytical Chemistry and Chromatography (6 papers). Xinchun Tong is often cited by papers focused on Cannabis and Cannabinoid Research (9 papers), Mass Spectrometry Techniques and Applications (7 papers) and Analytical Chemistry and Chromatography (6 papers). Xinchun Tong collaborates with scholars based in United States, United Kingdom and China. Xinchun Tong's co-authors include Robert A. Chase, Jack D. Henion, Angela Skelton, Lloyd M. Smith, Lauren P. Shearman, Jacquelyn Wright-Minogue, Tong Chen, B. R. Malcolm, Jianyi Cai and Shihao Xu and has published in prestigious journals such as Analytical Chemistry, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Xinchun Tong

52 papers receiving 1.6k citations

Peers

Countries citing papers authored by Xinchun Tong

Since Specialization

Citations

This map shows the geographic impact of Xinchun Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinchun Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinchun Tong more than expected).

Fields of papers citing papers by Xinchun Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinchun Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinchun Tong. The network helps show where Xinchun Tong may publish in the future.

Co-authorship network of co-authors of Xinchun Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Xinchun Tong. A scholar is included among the top collaborators of Xinchun Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinchun Tong. Xinchun Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyrazoles as non-classical bioisosteres in prolylcarboxypeptidase (PrCP) inhibitors 2014 ·Bioorganic & Medicinal Chemistry Letters ·Thomas H. Graham, Min Shu, Andreas Verras, Chen Qing, Margarita García‐Calvo, Xiaohua Li, JeanMarie Lisnock, Xinchun Tong, (unknown), Judyann Wiltsie, Jeffrey J. Hale, Shirly Pinto, Dong‐Ming Shen	15
2	Design of a novel class of biphenyl CETP inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Lu, (unknown), Ashleigh B. Theberge, Amjad Ali, Milton L. Hammond, Eugene Tan, Xinchun Tong, Suoyu Xu, Melanie Latham, Laurence B. Peterson, Matt S. Anderson, Suzanne S. Eveland, Qiu Guo, Sheryl A. Hyland, Denise P. Milot, Ying Chen, Carl P. Sparrow, Samuel D. Wright, Peter M. Sinclair	11
3	Furo[2,3-b]pyridine-based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation. Part 1 2010 ·Bioorganic & Medicinal Chemistry Letters ·John S. Debenham, (unknown), (unknown), Thomas F. Walsh, Junying Wang, Xinchun Tong, Sanjeev Kumar, Julie Lao, Tung M. Fong, Jing Chen Xiao, (unknown), Chun-Pyn Shen, Yue Feng, Donald J. Marsh, D. Sloan Stribling, Lauren P. Shearman, Alison M. Strack, Mark T. Goulet	25
4	Substituted fused bicyclic pyrrolizinones as potent, orally bioavailable hNK1 antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Gregori J. Morriello, Sander G. Mills, (unknown), Mikhail Reibarkh, Gary G. Chicchi, Julie A. DeMartino, Marc M. Kurtz, Philip R. Davies, (unknown), Song Guo Zheng, Xinchun Tong, Emma Carlson, (unknown), F.D. Tattersall, Alan Wheeldon, Susan Boyce, Neil Collinson, N.M.J. Rupniak, Stephen Moore, Robert J. DeVita	8
5	Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: Synthesis, SAR and biological evaluation 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), John S. Debenham, Thomas F. Walsh, Lin Yan, (unknown), Junying Wang, Xinchun Tong, Julie Lao, Tung M. Fong, Jing Chen Xiao, (unknown), Chun-Pyn Shen, D. Sloan Stribling, Lauren P. Shearman, Alison M. Strack, Mark T. Goulet, Jeffrey J. Hale	8
6	Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Hong C. Shen, Fa‐Xiang Ding, Qiaolin Deng, Suoyu Xu, Hsuan-Shen Chen, Xinchun Tong, Vincent Tong, Xiaoping Zhang, Yuli Chen, Gaochao Zhou, Lee-Yuh Pai, Magdalena Alonso‐Galicia, Bei Zhang, Sophie Roy, James R. Tata, Joel P. Berger, Steven L. Colletti	22
7	Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation 2009 ·Bioorganic & Medicinal Chemistry Letters ·John S. Debenham, (unknown), Junying Wang, Xinchun Tong, Julie Lao, Tung M. Fong, Marie‐Therese Schaeffer, Jing Chen Xiao, (unknown), Chun-Pyn Shen, D. Sloan Stribling, Lauren P. Shearman, Alison M. Strack, D. Euan MacIntyre, Jeffrey J. Hale, Thomas F. Walsh	16
8	2-Arylbenzoxazoles as CETP inhibitors: Substitution and modification of the α-alkoxyamide moiety 2009 ·Bioorganic & Medicinal Chemistry Letters ·Julianne A. Hunt, (unknown), (unknown), Milton L. Hammond, James V. Pivnichny, Xinchun Tong, Suoyu Xu, Matt S. Anderson, Ying Chen, Suzanne S. Eveland, Qiu Guo, Sheryl A. Hyland, Denise P. Milot, Carl P. Sparrow, Samuel D. Wright, Peter M. Sinclair	19
9	Molecular modeling aided design of nicotinic acid receptor GPR109A agonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Qiaolin Deng, (unknown), (unknown), Richard T. Beresis, Ning Ren, Tian‐Quan Cai, Andrew K.P. Taggart, Kang Cheng, Ester Carballo‐Jane, Junying Wang, Xinchun Tong, M. Gerard Waters, James R. Tata, Steven L. Colletti	20
10	Characterization of resistance mutations against HCV ketoamide protease inhibitors 2008 ·Antiviral Research ·Xinchun Tong, Stéphane Bogen, Robert A. Chase, Viyyoor Girijavallabhan, Zhiyong Guo, F. George Njoroge, Andrew Prongay, Anil K. Saksena, Angela Skelton, Ellen Xia	100
11	Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A 2007 ·Bioorganic & Medicinal Chemistry Letters ·Hong C. Shen, Michael J. Szymonifka, (unknown), Qiaolin Deng, Ester Carballo‐Jane, Kenneth K. Wu, Tsuei-Ju Wu, Kang Cheng, Ning Ren, Tian‐Quan Cai, Andrew K.P. Taggart, Junying Wang, Xinchun Tong, M. Gerard Waters, Milton L. Hammond, James R. Tata, Steven L. Colletti	16
12	The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidine 2007 ·Bioorganic & Medicinal Chemistry Letters ·Peter Lin, (unknown), Robert J. DeVita, Jonathan R. Young, (unknown), Xinchun Tong, Song Guo Zheng, Richard G. Ball, Nancy N. Tsou, Gary G. Chicchi, Marc M. Kurtz, Kwei‐Lan Tsao, Alan Wheeldon, Emma Carlson, Waisi Eng, H. Donald Burns, Richard Hargreaves, Sander G. Mills	11
13	Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), John S. Debenham, Thomas F. Walsh, (unknown), (unknown), Junying Wang, Xinchun Tong, Julie Lao, Tung M. Fong, Marie‐Therese Schaeffer, Jing Chen Xiao, (unknown), Chun-Pyn Shen, D. Sloan Stribling, Lauren P. Shearman, Alison M. Strack, D. Euan MacIntyre, Lex H.T. Van der Ploeg, Mark T. Goulet	11
14	A portal vein cannulation technique for drug discovery in mice 2007 ·Lab Animal ·Xiaolan Shen, (unknown), Tracy Johnson, (unknown), (unknown), Suoyu Xu, Jerrold M. Liesch, Xinchun Tong	9
15	Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Christopher W. Plummer, Paul E. Finke, Sander G. Mills, Junying Wang, Xinchun Tong, George A. Doss, Tung M. Fong, Julie Lao, Marie‐Therese Schaeffer, Jing Chen, Chun-Pyn Shen, D. Sloan Stribling, Lauren P. Shearman, Alison M. Strack, Lex H.T. Van der Ploeg	46
16	High-throughput pharmacokinetics screen of VLA-4 antagonists by LC/MS/MS coupled with automated solid-phase extraction sample preparation 2004 ·Journal of Pharmaceutical and Biomedical Analysis ·Xinchun Tong, Junying Wang, Song Guo Zheng, James V. Pivnichny	14
17	Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice 2003 ·Behavioural Pharmacology ·Lauren P. Shearman, Kim Rosko, (unknown), (unknown), Shihao Xu, Xinchun Tong, Beatriz Rocha	156
18	Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine 2000 ·British Journal of Pharmacology ·Matthew C. Walker, Xinchun Tong, Haley E. Perry, Mohammad S. Alavijeh, Philip N. Patsalos	57
19	Kinetic Monitoring of Enzymatic Reactions in Real Time by Quantitative High-Performance Liquid Chromatography-Mass Spectrometry 1995 ·Analytical Biochemistry ·(unknown), Xinchun Tong, Timothy Wachs, Bruce Ganem, Jack D. Henion	48
20	Solid-phase method for the purification of DNA sequencing reactions 1992 ·Analytical Chemistry ·Xinchun Tong, Lloyd M. Smith	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact